Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

GT Biopharma, Inc. (GTBP)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.7600-0.1100 (-5.88%)
At close: 04:00PM EDT
1.7600 0.00 (0.00%)
After hours: 04:49PM EDT
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 9/30/2022
Current
6/30/20223/31/202212/31/20219/30/2021
Market Cap (intraday)
58.14M91.77M93.16M97.79M205.63M
Enterprise Value
34.64M65.28M61.21M62.11M166.15M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/A
Price/Sales (ttm)
N/AN/AN/AN/AN/A
Price/Book (mrq)
3.775.164.253.055.64
Enterprise Value/Revenue
N/AN/AN/AN/AN/A
Enterprise Value/EBITDA
-1.09-21.91-11.25-3.45-30.47

Trading Information

Stock Price History

Beta (5Y Monthly) 0.55
52-Week Change 3-70.27%
S&P500 52-Week Change 3-16.62%
52 Week High 37.4800
52 Week Low 31.5100
50-Day Moving Average 32.4670
200-Day Moving Average 32.7193

Share Statistics

Avg Vol (3 month) 3114.38k
Avg Vol (10 day) 396.28k
Shares Outstanding 531.09M
Implied Shares Outstanding 6N/A
Float 824.99M
% Held by Insiders 115.85%
% Held by Institutions 110.21%
Shares Short (Sep 14, 2022) 4701.47k
Short Ratio (Sep 14, 2022) 45.51
Short % of Float (Sep 14, 2022) 42.36%
Short % of Shares Outstanding (Sep 14, 2022) 42.26%
Shares Short (prior month Aug 14, 2022) 4569.73k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Aug 20, 2017
Ex-Dividend Date 4N/A
Last Split Factor 21:17
Last Split Date 3Feb 10, 2021

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Jun 29, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-63.91%
Return on Equity (ttm)-123.31%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-31.89M
Diluted EPS (ttm)-1.0480
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)23.73M
Total Cash Per Share (mrq)0.76
Total Debt (mrq)223k
Total Debt/Equity (mrq)1.44
Current Ratio (mrq)2.78
Book Value Per Share (mrq)0.50

Cash Flow Statement

Operating Cash Flow (ttm)-15.63M
Levered Free Cash Flow (ttm)4.81M
Advertisement
Advertisement